Home Featured Page 142

Featured

Latest

Psilocybin for Chronic Suicidal Ideation: Scott T. Aaronson on Safety, an Efficacy Signal, and the Role of Expectations

Music in Psychedelic-Assisted Therapy: An Introduction to Sound, Playlist Curation, and Why Every Practitioner Needs to Understand Both

April 2026 Psychedelic Bill Round-up

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

The War on Drugs Is a War On Mothers and Their Children

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

How To Stop A Psychedelic Trip: The Promise of Ketanserin

Numinus to Participate in a Water Tower Research Fireside Chat on...

atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical...

FILAMENT HEALTH ANNOUNCES PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION...

PT374 – Personalizing Psychedelic Integration

Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting...

Psychedelic Bulletin #124: MAPS Wraps Second Phase 3 MDMA Trial; Preparing...

Why Did Psychedelics Relieve My Chronic Pain?

EDITOR PICKS

Psilocybin for Chronic Suicidal Ideation: Scott T. Aaronson on Safety, an...

Music in Psychedelic-Assisted Therapy: An Introduction to Sound, Playlist Curation, and...

April 2026 Psychedelic Bill Round-up

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psilocybin for Chronic Suicidal Ideation: Scott T. Aaronson on Safety, an Efficacy Signal, and the Role of Expectations

Music in Psychedelic-Assisted Therapy: An Introduction to Sound, Playlist Curation, and Why Every Practitioner Needs to Understand Both

April 2026 Psychedelic Bill Round-up

Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

The War on Drugs Is a War On Mothers and Their Children

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

How To Stop A Psychedelic Trip: The Promise of Ketanserin

Numinus to Participate in a Water Tower Research Fireside Chat on...

atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical...

FILAMENT HEALTH ANNOUNCES PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION...

PT374 – Personalizing Psychedelic Integration

Psychedelic Brains In A Dish

Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting...

Psychedelic Bulletin #124: MAPS Wraps Second Phase 3 MDMA Trial; Preparing...

Why Did Psychedelics Relieve My Chronic Pain?

EDITOR PICKS

Psilocybin for Chronic Suicidal Ideation: Scott T. Aaronson on Safety, an...

Music in Psychedelic-Assisted Therapy: An Introduction to Sound, Playlist Curation, and...

April 2026 Psychedelic Bill Round-up

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY